RecruitingPhase 2NCT06961955

5 vs. 9-day Course of Whole Breast Radiotherapy With Boost for Early-stage Breast Cancer

FAST NOVEMBER: A Phase II Randomized Trial of a 5 vs. 9-day Course of Whole Breast Radiotherapy With Boost for Early-stage Breast Cancer


Sponsor

University of Utah

Enrollment

144 participants

Start Date

May 21, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this study is to evaluate 5 days vs. 9 days of whole breast radiation.


Eligibility

Sex: FEMALEMin Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is comparing two schedules of radiation therapy after lumpectomy (breast-conserving surgery): a 5-day course versus a 9-day course — both of which are much shorter than the traditional multi-week approach. Researchers want to find out if a 5-day schedule works just as well for women with breast cancer who have certain higher-risk features. **You may be eligible if...** - You are a woman aged 18 or older - You have been diagnosed with invasive breast cancer or DCIS (early-stage non-invasive breast cancer) - Your cancer is stage T0–T3, N0, M0 (early-stage, no lymph node spread, no distant spread) - You had a lumpectomy within the past 84 days with clear surgical margins - You have at least one higher-risk feature (e.g., grade 3 cancer, low hormone receptor levels, lymphovascular invasion, close margins, or you are 50 or younger) **You may NOT be eligible if...** - You have cancer in both breasts - You had prior radiation to the chest - You had prior chemotherapy - Your cancer has spread to lymph nodes or other organs - You had a prior breast cancer in either breast - You have severe heart disease or a recent stroke or blood clot Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

RADIATIONRadiation Therapy

Undergo hypofractionated radiation therapy


Locations(1)

Huntsman Cancer Institute/University of Utah

Salt Lake City, Utah, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06961955


Related Trials